Long-term beta-blocker therapy in patients with myocardial infarction and preserved ejection fraction is increasingly questioned in the context of contemporary care.
Does long-term beta-blocker therapy improve outcomes in patients with myocardial infarction and preserved ejection fraction receiving contemporary care?
The necessity of long-term beta-blocker therapy in post-MI patients with preserved ejection fraction is being questioned, suggesting a potential need for guideline updates.
The role of long-term beta-blocker therapy in patients with myocardial infarction (MI) and preserved ejection fraction (EF) receiving contemporary care has increasingly been questioned.
Tomas Jernberg (2026) studied this question. Long-term beta-blocker therapy in patients with myocardial infarction and preserved ejection fraction is increasingly questioned in the context of contemporary care.